Cytosorbents (CTSO) Amortizatization of Intangibles (2010 - 2026)
Cytosorbents' (CTSO) quarterly Amortizatization of Intangibles came in at $282000.0 in Q2 2026, up 47.64% on a YoY basis from $191000.0 in Q2 2025, and down 3.09% quarter-over-quarter from $291000.0 in Q1 2026.
Powered by 
Analysis
Cytosorbents (CTSO) Amortizatization of Intangibles (2010 - 2026) Analysis & Trends
Cytosorbents (CTSO) has reported Amortizatization of Intangibles for 16 consecutive years, with $282000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Amortizatization of Intangibles rose 47.64% year-over-year to $282000.0; the trailing twelve-month figure through Jun 2026 stood at $1.0 million (up 82.67% YoY), and the FY2025 full-year result was $820000.0, up 209.43% from the prior year.
- Amortizatization of Intangibles fell to $282000.0 in Q2 2026 per CTSO's latest filing, from $291000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $398035.0 in Q4 2023 and bottomed at $45927.0 in Q1 2024.
- Historically, Amortizatization of Intangibles has averaged $137298.0 across 5 years, with a median of $64522.5 in 2022.
- The sharpest annual moves came in 2022 and 2023: Amortizatization of Intangibles plunged 86.07% in 2022, then surged 617.94% in 2023.
- Over 5 years, Amortizatization of Intangibles stood at $55441.0 in 2022, then soared by 617.94% to $398035.0 in 2023, then slumped by 68.09% to $127000.0 in 2024, then jumped by 96.06% to $249000.0 in 2025, then increased by 13.25% to $282000.0 in 2026.
- According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $282000.0, $291000.0, and $249000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 38.80 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 6.60 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | - |
| 10 | Cytosorbents | 20.00 Mn | 15.59 Mn | 7.05 Mn | 282,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 282,000.00 |
| Mar 31, 2026 | 291,000.00 |
| Dec 31, 2025 | 249,000.00 |
| Sep 30, 2025 | 190,000.00 |
| Jun 30, 2025 | 191,000.00 |
| Mar 31, 2025 | 190,000.00 |
| Dec 31, 2024 | 127,000.00 |
| Sep 30, 2024 | 46,000.00 |
| Jun 30, 2024 | 46,073.00 |
| Mar 31, 2024 | 45,927.00 |
| Dec 31, 2023 | 398,035.00 |
| Sep 30, 2023 | 55,440.00 |
| Jun 30, 2023 | 55,442.00 |
| Mar 31, 2023 | 55,439.00 |
| Dec 31, 2022 | 55,441.00 |
| Sep 30, 2022 | 64,522.00 |
| Jun 30, 2022 | 64,522.00 |
| Mar 31, 2022 | 64,523.00 |
| Dec 31, 2021 | 398,035.00 |
| Sep 30, 2020 | 35,869.00 |